Medscape3d
Drug-Induced Rashes in Skin of Color: Diagnostic Challenges
The risks, appearance, and consequences for drug-induced rashes often differ in patients with skin of color, further ...
FDA expands approval of breast cancer drug Kisqali to earlier stage patients
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat ...
NBC News5d
FDA expands approval of breast cancer drug Kisqali to earlier-stage patients
Odum was part of the group that took Kisqali plus hormone therapy. At one point, she developed a rash over her body and had to pause treatment. Even so, she said “for me, Kisqali was something ...
Indiatimes2d
Kisqali wins FDA nod for breast cancer treatment: Dosage, effectiveness and side effects of the breakthrough drug
The US Food and Drug Administration (FDA) has approved Kisqali for early stage breast treatment. Kisqali (ribociclib) is a selective cyclin-dependent kinase inhibitor, a class of drugs that help ...